Tokyo Tape
Sign in
← AuBEX

Quarterly report · Q3

3583.TEDINET S100Q49V
Period2022-04-01 → 2022-12-31
Filed2023-02-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥4.0bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥5.5bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥4.1bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥507m2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥558m2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥519m2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥727m2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥563m2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥561m2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥563m2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥365m2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥537m2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥395m2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥365m2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥395m2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥9.5bnat 2022-12-31Cons.Assets
Total assets¥9.4bnat 2022-03-31Cons.Assets
Total assets¥9.3bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥3.8bnat 2022-12-31Cons.Liabilities
Total liabilities¥4.0bnat 2022-03-31Cons.Liabilities
Net assets / equity¥5.7bnat 2022-12-31Cons.Net assets
Net assets / equity¥5.4bnat 2022-03-31Cons.Net assets
Net assets / equity¥5.2bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥2.6bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥2.5bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥131.722022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥34.342022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥194.042021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥142.82021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥51.612021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio60.3%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio57.4%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio56.2%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-12-31¥18m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-12-31¥344,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-12-31¥18m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31−¥6m
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentrevenue2022-04-01 → 2022-12-31¥1.1bn
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.1bn
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥3m
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentsegment profit2022-04-01 → 2022-12-31¥73m
jpcrp040300-q3r_E00584-000Technological Productsreportable segmentrevenue2022-04-01 → 2022-12-31¥2.9bn
jpcrp040300-q3r_E00584-000Technological Productsreportable segmentrevenue external2022-04-01 → 2022-12-31¥2.9bn
jpcrp040300-q3r_E00584-000Technological Productsreportable segmentsegment profit2022-04-01 → 2022-12-31¥669m
—segment totalrevenue2022-04-01 → 2022-12-31¥4.0bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥4.0bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥3m
—segment totalsegment profit2022-04-01 → 2022-12-31¥741m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥4.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥4.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥21m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥735m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-12-31¥8m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-12-31¥2m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-12-31¥6m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-12-31−¥17m
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentrevenue2021-04-01 → 2021-12-31¥1.0bn
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentrevenue external2021-04-01 → 2021-12-31¥1.0bn
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥3m
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentsegment profit2021-04-01 → 2021-12-31¥112m
jpcrp040300-q3r_E00584-000Technological Productsreportable segmentrevenue2021-04-01 → 2021-12-31¥3.0bn
jpcrp040300-q3r_E00584-000Technological Productsreportable segmentrevenue external2021-04-01 → 2021-12-31¥3.0bn
jpcrp040300-q3r_E00584-000Technological Productsreportable segmentsegment profit2021-04-01 → 2021-12-31¥689m
—segment totalrevenue2021-04-01 → 2021-12-31¥4.1bn
—segment totalrevenue external2021-04-01 → 2021-12-31¥4.1bn
—segment totalrevenue intersegment2021-04-01 → 2021-12-31¥3m
—segment totalsegment profit2021-04-01 → 2021-12-31¥801m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥4.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥4.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-12-31¥9m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥784m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 378
ItemContextValueUnit
Net defined benefit liabilityPrior1YearInstant390230000JPY
Net defined benefit liabilityCurrentQuarterInstant389311000JPY
Other nclPrior1YearInstant515000JPY
Other nclCurrentQuarterInstant515000JPY
Noncurrent liabilitiesPrior1YearInstant1710516000JPY
Noncurrent liabilitiesCurrentQuarterInstant1792610000JPY
LiabilitiesPrior1YearInstant4024729000JPY
LiabilitiesCurrentQuarterInstant3753700000JPY
Capital stockPrior1YearInstant1939834000JPY
Capital stockCurrentQuarterInstant1939834000JPY
Capital surplusPrior1YearInstant518489000JPY
Capital surplusCurrentQuarterInstant518489000JPY
Retained earningsPrior1YearInstant3109540000JPY
Retained earningsCurrentQuarterInstant3331344000JPY
Treasury stockPrior1YearInstant-212795000JPY
Treasury stockCurrentQuarterInstant-206244000JPY
Shareholders equityPrior1YearInstant5355068000JPY
Shareholders equityCurrentQuarterInstant5583423000JPY
Valuation difference on available for sale securitiesPrior1YearInstant35651000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant43233000JPY
Revaluation reserve for landPrior1YearInstant-39249000JPY
Revaluation reserve for landCurrentQuarterInstant27151000JPY
Foreign currency translation adjustmentPrior1YearInstant65005000JPY
Foreign currency translation adjustmentCurrentQuarterInstant57453000JPY
Valuation and translation adjustmentsPrior1YearInstant61407000JPY
Valuation and translation adjustmentsCurrentQuarterInstant127839000JPY
Net assetsPrior1YearInstant5416476000JPY
Net assetsCurrentQuarterInstant5711262000JPY
Liabilities and net assetsPrior1YearInstant9441206000JPY
Liabilities and net assetsCurrentQuarterInstant9464963000JPY
Net salesPrior1YTDDuration4075590000JPY
Net salesCurrentYTDDuration3965370000JPY
Cost of salesPrior1YTDDuration2596939000JPY
Cost of salesCurrentYTDDuration2516564000JPY
Gross profitPrior1YTDDuration1478651000JPY
Gross profitCurrentYTDDuration1448805000JPY
Selling general and administrative expensesPrior1YTDDuration920502000JPY
Selling general and administrative expensesCurrentYTDDuration942258000JPY
Operating incomePrior1YTDDuration558148000JPY
Operating incomeCurrentYTDDuration506546000JPY
Interest income noiPrior1YTDDuration375000JPY
Interest income noiCurrentYTDDuration386000JPY
Dividends income noiPrior1YTDDuration1481000JPY
Dividends income noiCurrentYTDDuration2217000JPY
Foreign exchange gains noiPrior1YTDDuration14437000JPY
Foreign exchange gains noiCurrentYTDDuration9991000JPY
Subsidy income noiPrior1YTDDuration－JPY
Subsidy income noiCurrentYTDDuration7667000JPY
Other noiPrior1YTDDuration4218000JPY
Other noiCurrentYTDDuration5470000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass